The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.

Iota Biosciences, a US-based bioelectronic medicine developer based on University of California (UC), Berkeley technology, has agreed to an acquisition by pharmaceutical firm Astellas, one of its existing shareholders. Financial terms of the transaction have not been disclosed. Iota is working on ‘neural dust’ technology developed at UC Berkeley with a view to its use…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.